miR-148a inhibits cell proliferation and migration through targeting ErbB3 in colorectal cancer

Area of Science:

• Oncology
• Molecular Biology
• Genetics

Background:

• Colorectal cancer (CRC) is a leading cause of cancer-related deaths globally.
• Downregulation of microRNA-148a (miR-148a) is implicated in various cancers, acting as an oncogene in CRC.
• The precise molecular mechanisms linking miR-148a and ErbB3 in CRC proliferation and migration remain unclear.

Purpose of the Study:

• To elucidate the molecular mechanisms underlying the roles of miR-148a and ErbB3 in colorectal cancer proliferation and migration.
• To investigate the regulatory relationship between miR-148a and ErbB3 in CRC cells.
• To identify the miR-148a/ErbB3 axis as a potential therapeutic target for colorectal cancer.

Main Methods:

• Quantitative real-time PCR (RT-qPCR) and Western blot analysis to measure miR-148a and ErbB3 expression.
• MTT and Transwell assays to assess cell proliferation and migration.
• Dual-luciferase reporter assay to confirm direct targeting of ErbB3 by miR-148a.

Main Results:

• miR-148a was found to be overexpressed in colorectal cancer, with its mRNA levels negatively correlated with ErbB3 expression.
• Upregulation of miR-148a significantly suppressed proliferation and migration in colorectal cancer cells.
• ErbB3 was confirmed as a direct target of miR-148a, with miR-148a inhibiting CRC cell proliferation and migration by binding to the 3'UTR of ErbB3 mRNA.

Conclusions:

• miR-148a inhibits colorectal cancer cell proliferation and migration by directly targeting and downregulating ErbB3 expression.
• The identified miR-148a/ErbB3 signaling axis provides novel insights into colorectal cancer pathogenesis.
• This axis represents a promising therapeutic target for colorectal cancer treatment.